22.7
Transcode Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
7.38
FY23:
4.46
FY24:
7.09
FY25:
22.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.21
FY22:
0.21
FY23:
0.71
FY24:
0.20
FY25:
140
Total assets
Change from FY21 to FY25
millions USD
FY21:
22.9
FY22:
7.59
FY23:
5.17
FY24:
7.29
FY25:
162
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.53
FY22:
4.35
FY23:
3.49
FY24:
2.77
FY25:
3.49
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
0.04
FY24:
6.54
FY25:
7.02
(positive)
Change from FY21 to FY25
millions USD
FY21:
20.4
FY22:
3.24
FY23:
1.64
FY24:
−2.02
FY25:
10.3
Total liabilities & equity
Change from FY21 to FY24
millions USD
FY21:
22.9
FY22:
7.59
FY23:
5.17
FY24:
7.29
FY25:
–
All amounts in millions USD